InspireMD, Inc. (NSPR)
Nasdaq · Healthcare · Medical Devices
$0.5801−6.81%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $27.0M
- 52-week range
- $0.58 – $2.54
- 52-week change
- −74.38%
- EPS (trailing)
- −$0.62
- Next earnings
- Nov 10, 2026
Fiscal year to Dec 2025
- Revenue
- $9.0M (+28.11%)
- Net income
- −$48.8M
- Operating margin
- −552.6%
- Diluted EPS
- −$0.76
- Free cash flow
- −$36.8M
From the company’s annual report on SEC EDGAR.
About InspireMD, Inc.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Headquarters: Miami, United States · 127 employees · inspiremd.com